Elicio Therapeutics, Inc.
ELTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601485
No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Elicio Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- 0 vs. Q1 2021
- Shares held
- 5.03M
- −86.2K (−1.7%) vs. Q1 2021
- Total value
- $66.5M
- −$25.4M (−27.7%) vs. Q1 2021
- New holders
- 5
- 11 more added
- Sold out
- 5
- 15 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $15.3M |
| Q1 2026 | 47 | $28.2M |
| Q4 2025 | 37 | $16.6M |
| Q3 2025 | 28 | $20.9M |
| Q2 2025 | 21 | $11.2M |
| Q1 2025 | 24 | $9.80M |
| Q4 2024 | 17 | $2.25M |
| Q3 2024 | 18 | $2.48M |
| Q2 2024 | 20 | $2.68M |
| Q1 2024 | 18 | $3.08M |
| Q4 2023 | 18 | $2.78M |
| Q3 2023 | 18 | $2.80M |
| Q2 2023 | 15 | $2.71M |
| Q1 2023 | 28 | $2.56M |
| Q4 2022 | 30 | $3.98M |
| Q3 2022 | 38 | $4.71M |
| Q2 2022 | 43 | $5.90M |
| Q1 2022 | 47 | $13.8M |
| Q4 2021 | 53 | $20.3M |
| Q3 2021 | 47 | $69.3M |
| Q2 2021 | 41 | $66.5M |
| Q1 2021 | 41 | $92.0M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Elicio Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 1,036,500 | $13.5M | 0.51% | +161,500+18.5% | Added |
| Park West Asset Management LLC | 1,006,289 | $13.0M | 0.38% | +39,635+4.1% | Added |
| Franklin Resources Inc | 615,000 | $8.01M | 0.00% | 00.0% | Unchanged |
| FMR LLC | 312,500 | $4.07M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 281,044 | $3.66M | 0.00% | −32,669−10.4% | Reduced |
| Vanguard Group Inc | 252,292 | $3.29M | 0.00% | −519,643−67.3% | Reduced |
| Stonepine Capital Management, LLC | 222,836 | $2.90M | 1.52% | +87,852+65.1% | Added |
| JPMorgan Chase & Co | 187,116 | $2.44M | 0.00% | +7,628+4.2% | Added |
| Birchview Capital, LP | 60,615 | $1.94M | 1.16% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 125,000 | $1.63M | 0.09% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 101,290 | $1.32M | 0.00% | +5,984+6.3% | Added |
| CM Management, LLC | 93,750 | $1.22M | 0.88% | 00.0% | Unchanged |
| State Street Corp | 85,405 | $1.11M | 0.00% | +38,400+81.7% | Added |
| Victory Capital Management Inc | 77,460 | $1.01M | 0.00% | −5,160−6.2% | Reduced |
| Northern Trust Corp | 64,531 | $839.0K | 0.00% | −193−0.3% | Reduced |
| Knoll Capital Management, LLC | 60,000 | $781.0K | 0.41% | 00.0% | Unchanged |
| HRT Financial LP | 59,857 | $779.0K | 0.01% | +59,857 | New |
| Jacobs Levy Equity Management, Inc | 57,146 | $744.0K | 0.01% | +57,146 | New |
| BLB&B Advisors, LLC | 56,847 | $740.0K | 0.05% | +56,847 | New |
| Millennium Management LLC | 48,059 | $626.0K | 0.00% | +14,799+44.5% | Added |
| STRS Ohio | 35,500 | $462.0K | 0.00% | +34,100+2,435.7% | Added |
| Charles Schwab Investment Management Inc | 33,210 | $433.0K | 0.00% | −1,608−4.6% | Reduced |
| Alyeska Investment Group, L.P. | 32,239 | $420.0K | 0.00% | −17,761−35.5% | Reduced |
| Morgan Stanley | 27,396 | $357.0K | 0.00% | +26,449+2,792.9% | Added |
| Citadel Advisors LLC | 23,864 | $311.0K | 0.00% | −11,092−31.7% | Reduced |
| Ergoteles LLC | 23,917 | $311.0K | 0.01% | +23,917 | New |
| CAPROCK Group, Inc. | 15,726 | $205.0K | 0.02% | 00.0% | Unchanged |
| Bank of America Corp | 9,114 | $119.0K | 0.00% | −8,619−48.6% | Reduced |
| California State Teachers Retirement System | 8,045 | $105.0K | 0.00% | −711−8.1% | Reduced |
| New York State Common Retirement Fund | 5,746 | $75.0K | 0.00% | +2,846+98.1% | Added |
| Deutsche Bank AG | 3,547 | $46.0K | 0.00% | −111−3.0% | Reduced |
| American International Group, Inc. | 3,253 | $42.0K | 0.00% | −131−3.9% | Reduced |
| Tower Research Capital LLC (TRC) | 1,091 | $14.0K | 0.00% | +359+49.0% | Added |
| Legal & General Group Plc | 570 | $7.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 472 | $6.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 397 | $5.00K | 0.00% | −167−29.6% | Reduced |
| Citigroup Inc | 276 | $4.00K | 0.00% | −109−28.3% | Reduced |
| UBS Group AG | 217 | $3.00K | 0.00% | −1,413−86.7% | Reduced |
| Toth Financial Advisory Corp | 150 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 100 | $1.00K | 0.00% | −1,810−94.8% | Reduced |
| TCI Wealth Advisors, Inc. | 37 | $0 | 0.00% | +37 | New |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −66,376−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −21,875−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −10,417−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −209−100.0% | Sold out |